Clinicopathogenetic significance of chromosomal abnormalities in patients with blastic peripheral B-cell lymphoma

Blood

Volumn 94, Issue 9, 1999, Pages 3114-3120

  Schlegelberger, Brigitte ^a   Zwingers, Thomas ^b   Harder, Lana ^b   Nowotny, Hadwiga ^b   Siebert, Reiner ^b   Vesely, Michael ^b   Bartels, Heinrich ^b   Sonnen, Ruth ^b   Hopfinger, Georg ^b   Nader, Alexander ^b   Ott, German ^b   Müller Hermelink, Konrad ^b   Feller, Alfred ^b   Heinz, Renate ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER SURVIVAL; CHROMOSOME 10; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION 8; CYTOGENETICS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOBLASTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; TRISOMY;

CHROMOSOME ABERRATIONS; GENETIC MARKERS; HUMANS; LYMPHOMA, B-CELL; TUMOR MARKERS, BIOLOGICAL;

EID: 20244373736     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lennert K, Feller AC: Histopathology of Non-Hodgkin's Lymphomas (based on the updated Kiel classification) with a section on clinical therapy by M. Engelhard and G. Brittinger. Berlin, Germany, Springer-Verlag, 1992
2. Engelhard M, Brittinger G, Huhn D, Gerhartz HH, Meusers P, Siegert W, Thiel E, Wilmanns W, Aydemir Ü, Bierwolf S, Griesser H, Tiemann M, Lennert K: Subclassification of diffuse large B cell lymphomas according to the Kiel classification: Distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. Blood 89:2291, 1997
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan T, Isaacson P, Knowles DM, Mason DY, Müller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
4. Jaffe ES: Introduction to the WHO Classification. Am J Surg Pathol 21:114, 1997
5. Zech L, Haglund U, Nilsson K, Klein G: Characteristic chromosomal abnormalities in biopsies and lymphoid cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer 17:47, 1976
6. Fukuhara S, Rowley JD, Variakojis D, Golomb HM: Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 39:3119, 1979
7. Vandenberghe E, De Wolf Peeters C, Wlodarska I, Stul M, Louwagie A, Verhoef G, Thomas J, Criel A, Cassiman JJ, Mecucci C, Van den Berghe H: Chromosome 11q rearrangements in B non-Hodgkin's lymphoma. Br J Haematol 81:212, 1992
8. Offit K, Jhanwar SC, Ladanyi M, Filippa DA, Chaganti RSK: Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer 3:189, 1991
9. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533, 1985
10. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097, 1984
11. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM: Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403, 1984
12. Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R. Alterations of a zinc finger-encoding gene, bcl-6, in diffuse large-cell lymphoma. Science 262:747, 1993
13. Poetsch M, Weber-Matthiesen K, Plendl HJ, Grote W, Schlegelberger B: Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artincial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol 14:963, 1996
14. Ott G, Kalla J, Ott MM, Schryen B, Katzenberger T, Müller JG, Müller-Hermelink HK: Blastoid variants of mantle cell lymphoma: Frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood 89:1421, 1997
15. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R: Classical and molecular cytogenetics of tumor cells, in Wegener R (ed): Cytogenetics. New York, NY, Springer-Verlag, 1999, p 151
16. Nowotny H, Karlic H, Grüner H, Hirsch J, Vesely M, Nader A, Heinz R: Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms. Ann Hematol 72:291, 1996
17. Mitelman F: ISCN: Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
18. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Metzke S, Joos S, Weber-Matthiesen K, Grote W, Schlegelberger B: Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24:q32) in B-cell lymphomas. Blood 91:984, 1998
19. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zühlke-Jenisch R, Plendl H, Metzke S, Joos S, Zucca E, Weber-Matthiesen K, Roggero E, Grote W, Schlegelberger B: Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle lymphomas. Ann Oncol 9:519, 1998
20. Shipp MA, Harrington DP, Anderson JR, Armitage JO, Bonadonna G, Brittinger G, Cabanillas F, Canellos GP, Coiffier B, Connors JM, Cowan RA, Crowther D, Dahlberg S, Engelhard M, Fisher RI, Gisselbrecht C, Horning S, Lepage E, Lister TA, Meerwaldt JH, Montserrat E, Nissen NI, Oken MM, Peterson BA, Tondini C, Velasquez WA, Yeap BY: A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 329:987, 1993
21. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328:1002, 1993
22. Schlegelberger B, Himmler A, Gödde E, Grote W, Feller AC, Lennert K: Cytogenetic findings in peripheral T cell lymphomas as a basis for distinguishing low grade and high grade lymphomas. Blood 83:505, 1994
23. Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M: Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316:79, 1987
24. Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3, 1998
25. Tilly H, Bastard C, Halkin E, Lenormand B, Bizet M, Dauce JP, Lees O, Monconduit M, Piguet H: del(14)(q22) in diffuse B-cell lymphocytic lymphoma. Am J Clin Pathol 89:109, 1988
26. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet 15:417, 1997
27. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
28. Johansson B, Mertens F, Mitelman F: Cytogenetic evolution patterns in non Hodgkin's lymphoma. Blood 86:3905, 1995
29. Bentz M, Werner CA, Döhner H, Joos S, Barth TFE, Siebert R, Schröder M, Stilgenbauer S, Fischer K, Möller P, Lichter P: High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood 88:1437, 1996
30. Thangavelu M, Olopade O, Beckman E, Vardiman JW, Larson RA, McKeithan TW, Le Beau MM, Rowley JD: Clinical, morphologic and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q11). Genes Chromosomes Cancer 2:147, 1990
31. Nashelsky MB, Hess MM, Weisenburger DD, Pierson JL, Bast MA, Armitage JO, Sanger WG: Cytogenetic abnormalities in B-immunoblastic lymphoma. Leuk Lymphoma 14:415, 1994
32. Schouten HC, Sanger WG, Weisenburger DD, Armitage JO: Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Nebraska lymphoma study group. Cancer Genet Cytogenet 47:73, 1990
33. Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, Ye BH, Lista F, Filippa DA, Rosenbaum A, Ladanyi M, Jhanwar S, Dalla-Favera R, Chaganti RSK: Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med 331:74, 1994
34. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezella F, Fruchart C, Duval C, Monconduit M, Tilly H: LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype and clinical outcome in 217 patients. Blood 83:2423, 1994
35. Juneja S, Matthews J, Lukeis R, Laidlaw C, Cooper I, Wolf M, Ironside P, Carson OM: Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma. Leuk Lymphoma 25:493, 1997
36. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, Seemanova E, Cooper PR, Nowak NJ, Stumm M, Weemaes CM, Gatti RA, Wilson RK, Digweed M, Rosenthal A, Sperling K, Concannon P, Reis A: Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93:467, 1998
37. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Döhner H: Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155, 1997
38. Weisenburger DD, Armitage JO. Mantle cell lymphoma - An entity comes of age. Blood 87:4483, 1996